Literature DB >> 26239984

Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.

Jennifer H Han1, Irving Nachamkin2, Susan E Coffin3, Jeffrey S Gerber4, Barry Fuchs5, Charles Garrigan2, Xiaoyan Han6, Warren B Bilker7, Jacqueleen Wise8, Pam Tolomeo8, Ebbing Lautenbach9.   

Abstract

Sepsis remains a diagnostic challenge in the intensive care unit (ICU), and the use of biomarkers may help in differentiating bacterial sepsis from other causes of systemic inflammatory syndrome (SIRS). The goal of this study was to assess test characteristics of a number of biomarkers for identifying ICU patients with a very low likelihood of bacterial sepsis. A prospective cohort study was conducted in a medical ICU of a university hospital. Immunocompetent patients with presumed bacterial sepsis were consecutively enrolled from January 2012 to May 2013. Concentrations of nine biomarkers (α-2 macroglobulin, C-reactive protein [CRP], ferritin, fibrinogen, haptoglobin, procalcitonin [PCT], serum amyloid A, serum amyloid P, and tissue plasminogen activator) were determined at baseline and at 24 h, 48 h, and 72 h after enrollment. Performance characteristics were calculated for various combinations of biomarkers for discrimination of bacterial sepsis from other causes of SIRS. Seventy patients were included during the study period; 31 (44%) had bacterial sepsis, and 39 (56%) had other causes of SIRS. PCT and CRP values were significantly higher at all measured time points in patients with bacterial sepsis. A number of combinations of PCT and CRP, using various cutoff values and measurement time points, demonstrated high negative predictive values (81.1% to 85.7%) and specificities (63.2% to 79.5%) for diagnosing bacterial sepsis. Combinations of PCT and CRP demonstrated a high ability to discriminate bacterial sepsis from other causes of SIRS in medical ICU patients. Future studies should focus on the use of these algorithms to improve antibiotic use in the ICU setting.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239984      PMCID: PMC4576082          DOI: 10.1128/AAC.00958-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

Review 1.  Epidemiology and control of antibiotic resistance in the intensive care unit.

Authors:  Jean Carlet; Adel Ben Ali; Annie Chalfine
Journal:  Curr Opin Infect Dis       Date:  2004-08       Impact factor: 4.915

Review 2.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

Authors:  Benjamin M P Tang; Guy D Eslick; Jonathan C Craig; Anthony S McLean
Journal:  Lancet Infect Dis       Date:  2007-03       Impact factor: 25.071

Review 3.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

5.  Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.

Authors:  Martijn D de Kruif; Maarten Limper; Herman Gerritsen; C Arnold Spek; Dees P M Brandjes; Hugo ten Cate; Patrick M Bossuyt; Pieter H Reitsma; Eric C M van Gorp
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

6.  Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay.

Authors:  Iraklis Tsangaris; Diamantis Plachouras; Dimitra Kavatha; George Michael Gourgoulis; Argirios Tsantes; Petros Kopterides; George Tsaknis; Ioanna Dimopoulou; Stylianos Orfanos; Evangelos Giamarellos-Bourboulis; Helen Giamarellou; Apostolos Armaganidis
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

Review 7.  The clinical consequences of antimicrobial resistance.

Authors:  Louis B Rice
Journal:  Curr Opin Microbiol       Date:  2009-08-27       Impact factor: 7.934

8.  In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP.

Authors:  Iwan A Meynaar; Wouter Droog; Manou Batstra; Rolf Vreede; Paul Herbrink
Journal:  Crit Care Res Pract       Date:  2011-05-15

9.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

Review 10.  Update on procalcitonin measurements.

Authors:  Michael Meisner
Journal:  Ann Lab Med       Date:  2014-06-19       Impact factor: 3.464

View more
  12 in total

1.  Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU.

Authors:  Russell R Miller; Bert K Lopansri; John P Burke; Mitchell Levy; Steven Opal; Richard E Rothman; Franco R D'Alessio; Venkataramana K Sidhaye; Neil R Aggarwal; Robert Balk; Jared A Greenberg; Mark Yoder; Gourang Patel; Emily Gilbert; Majid Afshar; Jorge P Parada; Greg S Martin; Annette M Esper; Jordan A Kempker; Mangala Narasimhan; Adey Tsegaye; Stella Hahn; Paul Mayo; Tom van der Poll; Marcus J Schultz; Brendon P Scicluna; Peter Klein Klouwenberg; Antony Rapisarda; Therese A Seldon; Leo C McHugh; Thomas D Yager; Silvia Cermelli; Dayle Sampson; Victoria Rothwell; Richard Newman; Shruti Bhide; Brian A Fox; James T Kirk; Krupa Navalkar; Roy F Davis; Roslyn A Brandon; Richard B Brandon
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

Review 2.  Could Biomarkers Direct Therapy for the Septic Patient?

Authors:  Clark R Sims; Trung C Nguyen; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

3.  Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis.

Authors:  Brendan J Kelly; Ebbing Lautenbach; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry D Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Jennifer H Han
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

4.  Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.

Authors:  Charles Garrigan; Jennifer Han; Pam Tolomeo; Katherine J Johnson; Stephen R Master; Ebbing Lautenbach; Irving Nachamkin
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

5.  Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.

Authors:  Brendan J Kelly; Ebbing Lautenbach; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry D Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Jennifer H Han
Journal:  Diagn Microbiol Infect Dis       Date:  2016-01-08       Impact factor: 2.803

6.  A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies.

Authors:  D L Sampson; B A Fox; T D Yager; S Bhide; S Cermelli; L C McHugh; T A Seldon; R A Brandon; E Sullivan; J J Zimmerman; M Noursadeghi; R B Brandon
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

Review 7.  Biomarkers of sepsis: time for a reappraisal.

Authors:  Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

8.  Influence of a 10-Day Mimic of Our Ancient Lifestyle on Anthropometrics and Parameters of Metabolism and Inflammation: The "Study of Origin".

Authors:  Leo Pruimboom; Begoña Ruiz-Núñez; Charles L Raison; Frits A J Muskiet
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

9.  Development and validation of a diagnostic model for early differentiation of sepsis and non-infectious SIRS in critically ill children - a data-driven approach using machine-learning algorithms.

Authors:  Florian Lamping; Thomas Jack; Nicole Rübsamen; Michael Sasse; Philipp Beerbaum; Rafael T Mikolajczyk; Martin Boehne; André Karch
Journal:  BMC Pediatr       Date:  2018-03-15       Impact factor: 2.125

10.  Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.

Authors:  Eric Gluck; H Bryant Nguyen; Kishore Yalamanchili; Margaret McCusker; Jaya Madala; Frank A Corvino; Xuelian Zhu; Robert Balk
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.